Gasparet, C., Gockerman, J. P., Diehl, L. F., De Castro, C., Moore, J., Long, G. D., … Rizzieri, D. A. (2008). Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma. BLOOD, 112(11), 1142–1142.

Gasparet, Cristina, Jon P. Gockerman, Louis F. Diehl, Carlos De Castro, Joseph Moore, Gwynn D. Long, Mitchell Horwitz, et al. “Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma.” BLOOD 112, no. 11 (November 16, 2008): 1142–1142.

Gasparet C, Gockerman JP, Diehl LF, De Castro C, Moore J, Long GD, et al. Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma. BLOOD. 2008 Nov 16;112(11):1142–1142.

Gasparet, Cristina, et al. “Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma.” BLOOD, vol. 112, no. 11, AMER SOC HEMATOLOGY, Nov. 2008, pp. 1142–1142.

Gasparet C, Gockerman JP, Diehl LF, De Castro C, Moore J, Long GD, Horwitz M, Chute J, Sullivan KM, Netuwirth R, Davis PH, Sutton LM, Anderson RD, Chao N, Rizzieri DA. Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma. BLOOD. AMER SOC HEMATOLOGY; 2008 Nov 16;112(11):1142–1142.